Drug History: LAMICTAL CD

DRUGS THAT CAUSES A FALSE POSITIVE ON A DRUG TEST

Browse by Letter: A B C D E F G H I J K L M N O P Q R S T U V W X Y Z 0-9

Label and Approval History

Drug Name:	LAMICTAL CD
FDA Application No:	(NDA) 020764
Active Ingredient(s):	LAMOTRIGINE
Company:	GLAXOSMITHKLINE

Label History

View the label approved on September 25, 2006 for LAMICTAL CD, (NDA) 020764

To see older, previously-approved labels, go to the "Approval History" section of this page. Older labels are for historical information only and should not be used for clinical purposes.

Approval History

Action Date	Supplement Number	Approval Type	Letters, Reviews, Labels, Patient Package Insert
3/17/2006	022	Labeling Revision
9/22/2006	020	New or Modified Indication	Letter Label Label
9/25/2006	020	Labeling Revision	Letter Label Label
9/22/2006	019	New or Modified Indication	Letter Label Label
9/25/2006	019	Labeling Revision	Letter Label Label
9/22/2006	018	New or Modified Indication	Letter Label Label
9/25/2006	018	Labeling Revision	Letter Label Label
9/22/2006	014	New or Modified Indication	Letter Label Label
9/25/2006	014	Labeling Revision	Letter Label Label
6/20/2003	011	New or Modified Indication	Letter Label Review
1/14/2004	009	Efficacy Supplement with Clinical Data to Support	Letter
2/23/2001	008	Labeling Revision
9/8/2000	006	Formulation Revision
5/25/2001	005	Efficacy Supplement with Clinical Data to Support	Label Review
6/8/1999	004	Manufacturing Change or Addition
9/22/2006	003	New or Modified Indication	Letter Label Label
9/25/2006	003	Labeling Revision	Letter Label Label
1/17/2003	002	New or Modified Indication	Label
12/14/1998	001	New or Modified Indication	Letter Label Review Dear Health Professional Letter
8/24/1998	000	Approval	Letter Label Review Dear Health Professional Letter Other Important Information from FDA

Therapeutic Equivalents